Allison Betof Warner, MD from Stanford Healthcare discusses recent advancements in treating advanced melanoma with a newly FDA-approved cell-based therapy. This innovative treatment is designed for patients who have not responded to traditional immunotherapy. Warner explains how the therapy works by extracting and expanding immune cells to target melanoma cells effectively. Highlighting its significance, she notes the high demand and hopeful outlook for this therapy, especially given the rising incidence of melanoma due to environmental factors. This breakthrough promises potential long-term control and improved patient outcomes for various cancers.